Conexeu Sciences, Inc. (CNXU)
7.15
+0.08
(+1.13%)
USD |
NASDAQ |
Aug 31, 16:00
7.08
-0.07
(-0.98%)
After-Hours: 20:00
Conexeu Sciences Shareholders Equity (Quarterly) : 7.196M for April 30, 2026
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| April 30, 2026 | 7.196M |
| October 31, 2025 |
| Date | Value |
|---|---|
| April 30, 2025 | |
| October 31, 2024 | 0.095M |
Shareholders' Equity Definition
Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| AbbVie, Inc. | -5.935B |
| Vericel Corp. | 370.04M |
| ACADIA Pharmaceuticals, Inc. | 1.307B |
| Alnylam Pharmaceuticals, Inc. | 1.354B |
| Anika Therapeutics, Inc. | 137.28M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 8.200M |
| Total Liabilities (Quarterly) | 1.003M |
| Current Ratio | 7.888 |